News

New member of CataloniaBio & HealthTech

We close the week with very good news! We are very happy to be part of CataloniaBio & HealthTech joining the +200 leading com...

Connect with Medichem at the Pharma Partnering Summit 2022

Join us at Pharma Partnering Summit 2022! 📢 This week, we will be attending Pharma Partnering Summit taking place on 12th & 1...

Elisabeth Stampa visited the European Commission

This week, our #CEO and President of Medicines for Europe, Elisabeth Stampa visited the European Commission. She met and e...

Innovation moves us

At Medichem, we invest in new products, applications, and technologies and encourage our teams to develop new ideas and bring them to success....

Medichem in BIO International Convention

At Medichem, we are excited to announce that we will participate for the 1st year. If you want to set up a meeting there, please contact us at...

Medichem in-cosmetics Global

#Chlorhexidine and #Octenidine are increasingly being used not only as an antiseptic to prevent hospital infections and as an adjuvant in oral...

Webinar Challenges, experience, and solutions scaling up flow chemistry

Have you registered for our upcoming #webinar? #23: Challenges, experience, and solutions scaling up flow chemistry Live session: Tuesday, ...

Medichem participates in euroPLX78

In Medichem, we are happy to announce our participation in #euroPLX78, April, 4th & 5th. It would be a pleasure to meet you. Please con...

DCAT Week

#dcat is just around the corner! Only one week to go. The #Medichemteam will be participating. Don't miss the chance to meet and discuss your ...

50th anniversary

This year, we celebrate our 50th #anniversary in the global #generic pharma industry. During these 50 years, in Medichem, we have been at t...

Our CEO Elisabeth Stampa president of Medicines for Europe products

It is an honor to share that our CEO Elisabeth Stampa will start the new mandate as #president of Medicines for Europe for the next two years....

Malta, meeting point

Last week we shared our experiences in an event organized by The Embassy of the Republic of Malta in Spain and the Madrid ...

Our CEO Elisabeth Stampa and the whole team of Medichem Manufacturing (Malta) Ltd. had the pleasure to greet some distinguished guests to our manufacturing plant

Last week was very exciting, our CEO Elisabeth Stampa and the whole team of Medichem Manufacturing (Malta) Ltd. had the pleasure to greet some dis...

Our CEO Elisabeth Stampa today in DCAT Values Chain Insights: 5 Minutes With

Our CEO Elisabeth Stampa today in DCAT (Drug, Chemical & Associated Technologies Association) Values Chain Insights: 5 Minutes With.  T...

Medicines for Europe & EFCG – European Fine Chemicals Group press release

COVID crisis revealed the problems generated when Europe became too dependent on critical products manufactured overseas. Si...

The European Week for Waste Reduction

13th edition, 30 countries involved, more than 12,000 actions…. The European Week for Waste Reduction is coming to an end, but it's not just a mat...

Project Co-financed by CDTI and ERDF funds

The project "Research and development of a drug for the treatment of acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma...

Our CEO Elisabeth Stampa won the #eWoman award by CaixaBank

Last week our CEO Elisabeth Stampa won the #eWoman award for Career Achievement by CaixaBank. This award promotes equality and progress throug...

Last day of CPhI Worldwide

We made a nice start and we are finished today. Team is super happy. We have missed many colleagues and partners but grateful for those who st...

Apixaban API has been approved by China NMPA

One step further with Apixaban. We are happy to announce that Apixaban API has been approved by China NMPA. 🎉🎉 This is a significant milest...

Annual Conference of Medicines for Europe

After one year break due to COVID 19, two weeks ago, we all gathered for the Annual Conference of Medicines for Europe, we share the main...

Elisabeth Stampa will be part of the “CaixaBank Businesswoman Community”

We would like to congratulate our CEO Elisabeth Stampa, who is eligible for the national award and to be one of the Spanish representatives of...

CPhI Worldwide

In 2020, CPhI was unfortunately cancelled and we did not have the opportunity to meet industry colleagues. This year CPhI will be happeni...

Medichem’s Management Team met

Medichem's Management Team met late July to further analyze how to continue improving the service provided to our partners and customers and hel...

E-commerce of APIs? Why not?

Medichem has joined Kemiex platform to explore new opportunities and make its products and support further available.

Looking for Generic FDFs online?

Medichem has joined Bioseet platform to expand its customer base and explore new potential cooperations worldwide.

DCAT virtual week is almost there!

We have so many new things to explain that we would love to meet you! If you want to hear more, book a slot with us!

Prucalopride, launch in Europe

We are pleased to announce that this week we received the confirmation of the launch of Prucalopride in Europe. This is a 100% vertically inte...

Quality Indicators from an API manufacturer perspective

Ms. Mariona Senis, Quality Director of Medichem, S.A., participated as a guest speaker in the training program on Indicators of the Quality Sy...

Global Recycling Day 17th May

Find out the way Medichem contributes to Global Sustainability.

World Day for Safety and Health at Work

Many workshops organized on 28th April at different Medichem sites to help improve health and safety at work: respiratory protection, hand pro...

Apixaban

We are pleased to announce that the DCP Marketing Authorization related to Medichem Apixaban 5 mg and 2.5 mg film-coated tablets was grant...

Medicines for Europe

Today, February 26th, Elisabeth Stampa, CEO of Medichem, has participated in the High-level launch event of the EU structured dialogue for the...

Medicines for Europe’s press release

We would like to share Medicines for Europe’s press release on the EU dialogue organized by the European Commission last 26th February to disc...

New Site!

Our shiny new site is now live! Check it out and discover: * Our customers' stories and how we go “beyond the pill” by providing unique benef...

Season’s Greetings from all of us at Medichem!

This year has certainly been extraordinary and we would like to express our deep gratitude for your trust. We wish you an enjoyable holiday seas...

Medichem is committed to providing products with added value while minimizing its environmental impact

We strive to reach the United Nations Sustainable Development Goals and integrate them into our daily operations. This month, we would like to t...

For a healthy Europe – F.A.Z. Konferenzen

On October 7th, Medichem participated in the conference for a #healthyeurope to discuss how European industrial policy should strengthen API supp...

Introducing Sugammadex Sodium made by Medichem

Sugammadex Sodium is an injectable solution indicated for the reversal of neuromuscular blockade in anesthesia. Medichem is a vertically ...

CERTIFICATION AND MEMBERSHIPS

Auditors have praised Medichem’s environmental management system after this year’s follow-up certification audit (for ISO 14001: 2015) of the pro...

Sunitinib Malate by Medichem: manufactured in the EU, available worldwide

Sunitinib malate is an oral tyrosine kinase inhibitor (TKI) used to treat renal carcinoma and gastrointestinal stromal tumors. Medichem’s Suniti...

A Policy Roadmap for Medicines Manufacturing Leadership

As part of our work with @Medicines for Europe, we have developed a policy roadmap for medicines manufacturing in Europe. The #COVID19 crisis has ...

ASIA Q1´20 – Latest Authorizations

  Medichem´s DMFs for the Active Pharmaceutical Ingredient of Paroxetine and Rivaroxaban are filed and listed on the CDE website, China – Q...

Corporate Announcement 14.03.2020

  Dear Customer, Like many of you we have been closely following the developments about coronavirus. At Medichem we deeply care about our ...

Q4’19 – Latest Authorizations by the Regulatory Agencies – Asia

  Medichem receives the Approval Notice Letter by the Korean Authorities for Apixaban´s Active Pharmaceutical Ingredient – Q4’19 Mediche...

Medichem Cares, Sustainable Environment

Sustainable Environment by Medichem

Medichem’s R&D and Business Development summit in ESADECREAPOLIS

What could be more inspiring than the ESADECREAPOLIS meeting rooms for Medichem's R&D and Business Development summit? On July 9th and 10th,...

USP’s Donor Recognition Program would like to recognize Medichem for its contributions…

      "USP’s Donor Recognition Program would like to recognize Medichem for its contributions during the 2018 calendar year" Says...

“Fostering The Culture of Innovation and Excellence”

      On June 26th, Medichem participated in a Design Thinking Workshop organized by Ship2B. In line with Medichem´s Culture of ...

We are proud to announce that Medichem´s Rivaroxaban 2.5mg, 10mg, 15mg and 20 mg DCP has been approved! … And API Rivaroxaban EU and US DMFs have been successfully filed!

First European APIs, Sugammadex and Apixaban, filed to the NMPA!

Medichem Announcement 2019

First to obtain the DCP authorization for Sugammadex in Europe!

Seasons greetings!

Ampliación de la Capacidad Productiva / Production Capacity Expansion

      Medichem has carried out a project from 2016- till 2017 to expand the production capacity of its plant in Celrà, which...

Visit us at CPhI Madrid!

Medichem at DCAT 2018. 19th to 22nd March in New York City.

CPhI Worldwide 24th-26th October 2017 Frankfurt

Combino Pharm’s solid oral dosage forms plant in Malta passes US FDA inspection

      A favorable US FDA inspection at Medichem’s subsidiary Combino Pharm’s plant in Malta opens the door to the commercializati...

Christmas 2016

Medichem launches Award in Organic Chemistry

We are proud to announce that Medichem Manufacturing (Malta) Ltd. has been one of sponsors of this year's annual National Chemistry Symposium, orga...

Medichem at DCAT 2016. 14th to 17th March in New York City

FDA inspection in Celrà (Spain) with no “Form 483” for the sixth consecutive time

The latest US FDA inspection of our plant in Celrà (Girona), Spain in April resulted in no “Form 483” (no observations were noted). For the Celrà s...

Medichem at CPhI Japan in Tokyo, April 22nd – 24nd 2015 (booth Nr. 1F-27)

Medichem at DCAT Week ’15, March 16th-19th 2015 in New York

Medichem: Launch of our new website

We are happy to announce the launch of our Medichem’s new website which uses our new corporate identity.      

DO YOU KNOW WHAT FLOW CHEMISTRY IS?

Flow Chemistry is a technique involving the use of structured devices, also called microreactor or flow reactors, where reactants are combined and ...

DID YOU KNOW THAT CHLORHEXIDINE DIGLUCONATE IN ORAL CARE…?

FACTS ABOUT CHLORHEXIDINE IN ORAL CARE Chlorhexidine is an antiseptic and antimicrobial often used as an active ingredient in oral rinse. ...

FDA inspection in Hal Far (Malta) with no “Form 483” for the second consecutive time

Medichem Malta plant passed a US FDA inspection for the second consecutive time without receiving any observation. The inspection of Medichem’s pl...

Installation of Continuous Flow reactor at industrial scale in our plant in Spain

Start operations of High Potency API plant in Malta

In May 2014, Medichem opened a brand new High Potency API unit (HPAPI) in its Maltese plant, located in Hal Far. The HPAPI modular laboratory is a ...

FDA inspection in Celrà (Spain) with no “Form 483” for the fifth consecutive time

The latest FDA inspection of our plant in Celrà (Girona), Spain in September resulted in no “Form 483” (no observations were noted). The inspectio...

Set up of Nanjing Medichem Biopharmaceutical Development Co. Ltd, our R&D Center in Nanjing, China

FDA inspection in Hal Far (Malta) with no “Form 483”

The latest FDA inspection of our plant in Hal Far (Malta) in April resulted in no “Form 483” (no observations were noted). Times of Malta

40th anniversary of the foundation of the company

This year, we celebrate our 40th anniversary in the global pharmaceutical industry. During these 40 years, our goal has always been constant innov...

FDA inspection in Celrà with no form-483 for the fourth consecutive time

The latest FDA inspection of our Spanish plant in Celrà (Girona) in April resulted in no form 483 (no observations were noted) for the fourth conse...

Plant in Malta inspected by the FDA

The Malta plant in Hal Far, which started operations in November 2005, received FDA inspection in December 2007

Medichem exhibited at CPhI Tokyo in Japan for the first time

FDA inspection in Celrà with no form-483 for the third consecutive time

The latest FDA inspection of our plant in Celrà in Spain conducted in November resulted in no form 483 (no observations were noted) for the third c...

New production plant in Malta

Medichem inaugurated its new production plant in Hal Far in Malta in November 2005. The plant is equipped with the state-of-the-art equipment and ...

November 2005 – Visit of President of Malta to our plant in Celrà

On 10th November His Excellency Dr. Edward Fenech-Adami, President of Malta, paid a visit to our facilities in Celrà, Spain. President Fenech Adami...

FDA inspection in Celrà with no form-483

Since 1985 our plant in Celrà in the province of Girona in Spain has been regularly inspected and found acceptable by the FDA. For the second cons...